Sierra Leone advances pandemic preparedness with operationalisation of the Pandemic Fund
Sierra Leone has entered a critical phase in strengthening its pandemic preparedness and response capacities, officially flagging-off the operationalisation of the Pandemic Fund. This milestone signals the country's continued commitment to protecting communities and contributing to global health security.
The project is led by the National Public Health Agency (NPHA), with the World Health Organization (WHO) serving as the lead implementing entity. Other key implementing partners include the Food and Agriculture Organization (FAO), UNICEF and the World Bank, reflecting a multi-sectoral, One Health approach that recognizes the interconnectedness of human, animal, and environmental health.
Sierra Leone's successful application to the highly competitive Pandemic Fund demonstrates the Government's growing leadership in global health security. This achievement was made possible through sustained collaboration, with WHO and partners providing technical guidance to shape a proposal aligned with international standards and responsive to national health priorities.
The Pandemic Fund offers a transformative opportunity to strengthen Sierra Leone's capacity to prevent, detect, and respond to public health threats with greater speed and efficiency. Targeted investments will focus on enhancing disease surveillance, laboratory capacity, health workforce development, and emergency operations, building a more resilient and responsive health system.
Speaking at the flag-off, on behalf of the Minister of Health, Dr Austin Demby, the Deputy Minister 2 for Agriculture and Food Security, Mr Sahr Hemore, emphasized: 'We are working assiduously to ensure the health and protection of our citizens against diseases and to contribute to global health security.'
The timing of this investment is critical. In recent years, Sierra Leone has faced a number of public health emergencies, including the ongoing mpox outbreak, which have exposed systemic vulnerabilities despite the tireless efforts of frontline health workers. The fund aims to address these gaps, while laying the foundation for sustainable, long-term preparedness.
'Sierra Leone's operationalisation of the pandemic fund represents a significant milestone,' said Dr George Ameh, WHO Representative in Sierra Leone. 'The responsibility to deliver rests with all of us, and WHO remains committed to providing technical support throughout the implementation.'
WHO's role goes beyond the initial design phase. As the lead implementing entity, WHO will continue to provide technical expertise in operational planning, capacity building, monitoring, and evaluation, to ensure that investments translate into measurable, sustainable outcomes. This partnership underscores WHO's commitment to country-led efforts that advance both national priorities and global health security.
Sierra Leone's approach serves as an example of how multi-partner collaboration, anchored in strong national leadership, can drive meaningful progress in pandemic preparedness. Sustained success will depend on transparent governance, inclusive coordination, and accountability to both national stakeholders and international partners.
With continued support from WHO, FAO, UNICEF, and the World Bank, Sierra Leone is poised to build a legacy of preparedness that will protect current and future generations and contribute to regional and global health security efforts.
Distributed by APO Group on behalf of World Health Organization - Sierra Leone.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The National
a day ago
- The National
A cancer crisis is inevitable. What can we do about it?
The number of cancer patients is set to rise dramatically throughout the entire Gulf region. This is simply because of changes in the age of its population. Cancer can, of course, occur at any age but it predominantly occurs in older people. In the UK, 25 per cent of the population is now over 60 compared to only 3.6 per cent in the UAE. The number of new cancer patients in this region per million people is currently less than half that in Europe. But this is set to change rapidly with a much more European age pattern coming to all GCC countries. The risk factors for cancer due to age are already locked-in, so a health crisis is inevitable. There will be a significant rise in both incidence (the number of new cases) and prevalence (the number of patients living with cancer). The World Health Organisation predicts a more than doubling of both in the GCC region by 2050. The 'big four' cancers are those arising in breast, colon, lung and prostate, which make up 65 per cent of diagnoses. Each cancer has its own age profile and causation. As breast cancer starts rising in women in their forties, it is unsurprising that we are already seeing a huge increase. The other types will surely follow in the next decade. But a real puzzle is emerging. Over the past 20 years, we have seen a dramatic increase of certain cancers in the 30-50 age group globally. This trend started in the 1990s, so has nothing to do with Covid-19 or its vaccines. Lymphoma, melanoma, head and neck as well as the big four cancers are all involved. What is going on and what can we do about it? We know that age is the biggest risk factor and we just cannot stop the clock. But changing lifestyles are definitely involved too. The interplay of diet, exercise and obesity can alter the hormonal balance in the body. How we work, play and relax now is different from the past. Only three generations ago, the Gulf was a land of nomadic tribesmen with a healthy lifestyle. Subsequent generations now sit in smart high-rise offices, often with sedentary lifestyles and a diet heavy with processed food. But why is this increasing the risk of cancer? Our lifestyle contributes to the composition of the microbiome – the bugs that colonise our intestines breaking down potential carcinogens and toxins. Powerful data-mining artificial intelligence programmes are being used to study the huge number of variables involved. Within five years, it is likely we will understand more clearly the factors causing defects in cell growth control that allow rogue cells to emerge. These become the enemy within – the cancer. Greater understanding will allow specific tailored cancer prevention advice to individuals. Prevention and screening messages are always far more powerful if individualised. Risk-based screening for common cancers will be revolutionised by multi-cancer early detection tests, or MCEDs. These pick up abnormal DNA fragments released by tiny early cancers which circulate in the blood. Although there are several on the market, they produce too high a false positive rate to be used on everyone. They can make the worried well even more worried. Eventually, a reliable, self-administered finger prick sample will be enough to diagnose cancer accurately, but we're just not there yet. Understanding the reasons that cancer arises at a molecular level will lead to both better prevention and more effective treatment strategies. But oncologists need to steer a delicate path between hope, hype and reality for this increasingly common disease Technology will allow us to diagnose cancer in its very early stages where outcomes are best. The Gulf is well provided with increasingly sensitive diagnostic scanners, both MRI and CT. And molecular analysis of biopsies from cancers will provide far more personalised individual drug and radiation combinations. The future physicians' laptop will not only choose the optimal therapy but also predict probable unpleasant side effects. AI will be used extensively to understand individual interactions to treatments – both good and bad allowing perfect personalisation. The Gulf has many excellent cancer treatment facilities. But there are few effective networks allowing the combination of international expertise bringing multi-disciplinary opinions for patients and yet delivering care close to their homes currently in place. Treating cancer effectively is no quick fix, often taking several months of frequent hospital visits for radiotherapy and chemotherapy. The medical tourism model used for elective surgery is not feasible. The increasing cost of optimal cancer care is driving government health bodies globally to reduce the wide inconsistencies in treatment protocols. Networked care from a mixed economy of public and private providers is very much the future. It allows the development of a financially sustainable model adapted to a country's overall wealth. Increasing financial investment into an individuals' cancer care obviously increases the benefit to the patient. But there is a limit – a therapeutic plateau – where further spending brings no benefit for the patient. Poorer countries such as those of middle Africa operate well below it; most of Europe and Asia is comfortably at its beginning but the US is far along it, spending vast sums of money for no gain in the last few months of a patients' life. Networked care is the solution to providing the best individual treatment and yet minimising its toxicity both for the patient and financially for the payor. Coupling the intellectual power of a large central university hospital with skilled technical care close to home is what families want. Currently we cure over 90 per cent of patients with early-stage cancer. When the disease has spread outside its organ of origin, this figure drops dramatically. So, the emphasis has to be on streamlining the diagnostic phase and fast-tracking treatment. The current emphasis is very much on maintaining the best quality of life both during and after therapy. We are now far more honest with our patients and try to manage their expectations with frankness. Breakthroughs appear in the media regularly driven by commercial interests from biotech and pharma companies and their investors. Their hyped-up message can often raise false hope. Public education and better screening lead to earlier diagnosis and better outcomes. Understanding the reasons that cancer arises at a molecular level will lead to both better prevention and more effective treatment strategies. But oncologists need to steer a delicate path between hope, hype and reality for this increasingly common disease.
Zawya
a day ago
- Zawya
Stronger Health Through Smarter Taxes in Mauritius
WHO has joined forces with VISA NGO and the University of Cape Town to assess the impact of increasing health taxes in Mauritius. Using a simulation tool, the study examined how tax hikes affect tobacco use, government revenues, and premature deaths. A 15% annual cigarette tax increase could: Boost excise revenue by 55% Reduce smoking prevalence from 18.1% to 17.4% Prevent 11,600 premature deaths by 2029 Even more ambitious action—a 25% annual increase—could: Double excise revenues Lower smoking prevalence to 16.3% Save 19,300 lives by 2029 On 20 June 2025, WHO convened high-level officials from the Ministries of Health and Finance to discuss the findings, presented by the University of Cape Town's Research Unit on the Economics of Excisable Products and a WHO taxation expert. WHO and VISA echoed the study's call for regular, significant tax increases—one of the most effective ways to curb noncommunicable diseases (NCDs) Earlier, on 26 May, VISA and WHO presented the findings to key stakeholders including the Mauritius Revenue Authority, Ministries of Education and Youth, the University of Mauritius, NGOs, and consumer groups. WHO also applauded the Government's recent decision to raise taxes by 10% on tobacco and alcohol, and 100% on sugary drinks, extending it to products like chocolate and ice cream. 'This is a gift to public health,' said Dr. Anne Ancia, WHO Representative. 'Higher prices on unhealthy products help reduce consumption—especially in a country where obesity, diabetes and cardio-vascular diseases are leading causes of death and disability.' Dr. Ancia also stressed the urgent need to enforce the Tobacco Law 2022, particularly the ban on single-stick sales, which undermines progress in reducing tobacco use through higher prices. Distributed by APO Group on behalf of World Health Organization (WHO) - Mauritius.
Gulf Today
a day ago
- Gulf Today
UAE-funded maternity clinics bringing hope to Afghan families
In Jalalabad, Nangarhar province, Afghanistan, Shazia Mohammadi cradles her newborn daughter, Fatima, her seventh child, but the first to be born in a medical clinic. For the first time, Shazia experienced childbirth with access to doctors, medicines, and professional care. Her daughter was also the first baby delivered at one of ten new maternity clinics built by the UAE across Afghanistan, marking the start of a new chapter for maternal health in rural areas. 'Our economic condition was pretty bad all through. Now, thanks to the help we have received, we are much better off. We thank the UAE for this transformation in our lives,' Shazia said. Her husband, Ramadan Mohammadi, recalled their struggles to access care in the past. 'Six of our children were born at home because we couldn't afford transportation to distant hospitals. This is the first time a clinic has been built near our house, and it has been a blessing for us.' These UAE-funded clinics have brought much needed medical care to communities that have long lacked access to even the most basic health services. Located in seven provinces – Nangarhar, Balkh, Herat, Paktia, Paktika, Helmand, and Kandahar – the facilities offer maternity and paediatric care, counselling, contraceptive services, emergency care, medicines and referrals for high-risk cases. They also serve as hubs for community outreach, offering health education, awareness programmes, and life-saving vaccinations, including for COVID-19 and BCG to protect against tuberculosis, to more than 20 people each day. Dr. Ikramullah, a doctor at one of the clinics described the change underway, 'Previously, childbirth happened at home, without any medical support, in unsafe, unhygienic conditions. It is changing now, and the people here are so delighted. We not only ensure safe deliveries, but also provide vaccinations, nutritional assistance, and continuous medical care for mothers and newborns.' He pointed to a young child named Ayesha Qamari as an example of the progress being made, 'The impact of these maternity centres is already being felt. This baby is just one of hundreds of children receiving crucial health checks and vaccinations. This will help bring down the high infant mortality rate in Afghanistan, one of the highest in the world.' According to UNICEF, more than 57 children out of 1,000 in Afghanistan die before reaching the age of five. Ayesha's mother shared her experience, 'We have come to the clinic three or four times. Earlier, we could not afford the cost of transport to the city hospital. Many times, the sick children would not survive the long journey. We are deeply indebted to the UAE for building this clinic in our vicinity.' Beyond healthcare, the initiative is also revitalising the local economy. Small businesses – offering services such as transportation and food supply – have emerged around the clinics and over 100 Afghans have been employed in a range of roles, from medical support to administration. Mawlawi Ameenullah Sharif, Health Director of Nagarhar Province, noted the broader impact, 'We thank the UAE for their investment in Afghanistan's healthcare. This clinic was urgently needed, and now, the poor have access to essential services, including vaccinations, maternal care, and nutrition support.' The clinics are all state-of-the-art, equipped with advanced medical equipment, solar power, mobile units, and ambulances – and staffed by dedicated healthcare professionals. They reflect the UAE's commitment to improving quality of life, empowering women and children, and strengthening local communities in Afghanistan. Expected to impact the lives of more than 100,000 women in the coming years, these facilities represent a transformative step toward accessible healthcare in some of the country's most underserved areas.
